BRLI...small float...Friday September 24, 7:30 am Eastern Time
Company Press Release
Bio-Reference Announces Drug Screen Website: www.drugscreenlab.com
ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Sept. 24, 1999--Bio-Reference Laboratories, Inc (Nasdaq Small Cap ''BRLI'') announced today the opening of the Bio-Reference Laboratory drug screen website ''WWW.DRUGSCREENLAB.COM'' which will provide a full suite of drug-related medical and technical information for both professionals and non-professionals. The site is for anyone with questions or concerns about drug testing procedures and services, drug testing requirements and laws throughout the country and drug-related resources. Bio-Reference has dedicated substantial resources and facilities in becoming a premier solution for clinical drug issues and services. This site offers those solutions and the associated knowledge base to the worldwide information highway and is the basis of Bio-Reference's drug screening services which has been recently expanded from the New York/New Jersey area to new areas including Maryland, Pennsylvania and Virginia.
WWW.DRUGSCREENLAB.COM has been designed to provide both answers and solutions. Professionals and non-professionals have legal, social and technical questions regarding drug testing and the use of clinical drug testing in both the home and the marketplace. This website will provide answers to those questions and links to other regulatory and technical sites that can expand upon those answers. The site further provides links and information about the Bio-Reference solutions to those issues.
''This website is another step in our effort to service from a transaction-based clinical laboratory to becoming a Healthcare Services and Information Company,'' stated Dr. Marc Grodman, President and CEO of Bio-Reference Laboratories, Inc. ''We recently announced the formation of a new business unit which is dedicated to utilizing leading-edge information technologies sciences to enhance medical management strategies. Our new Internet site is simply the first of many steps we intend to take to provide total healthcare solutions.''
Bio-Reference Laboratories, Inc. is a multi-faceted Health Services and Information Company which includes a highly automated computer-driven clinical laboratory serving markets in the New York/Tri-State metropolitan area.
Statements included in this release that are not historical in nature, and are intended to be, and are hereby identified as ''forward-looking statements'' for purposes of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including, without limitation, those relating to the Company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements, including economic, competitive, technological, governmental regulation and other risks identified from time to time in the Company's reports filed with the Securities and Exchange Commission.
The company's common stock is traded on the Nasdaq Small Cap system under the symbol ''BRLI.''
|
